Camostat Mesilate - CAS 59721-29-8
Catalog number: 59721-29-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Camostat (INN) or FOY-305 is a serine protease inhibitor. Serine protease enzymes have a variety of functions in the body, and so camostat has a diverse range of uses. It is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease orpancreatitis.
Publictions citing BOC Sciences Products
  • >> More
Related CAS:
59721-28-7 (Free base)
Solid powder
4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonate; Camostat Mesilate; Camostat Mesylate; FOY 305; FOY-305; FOY305
Canonical SMILES:
1.The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M1, Shimotai Y2, Hatachi Y3, Lusamba Kalonji N4, Tando Y5, Kitajima Y6, Matsuo K7, Kubo H4, Nagatomi R6, Hongo S2, Homma M8, Nishimura H8. Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10.
BACKGROUND: Serine proteases act through the proteolytic cleavage of the hemagglutinin (HA) of influenza viruses for the entry of influenza virus into cells, resulting in infection. However, the inhibitory effects of serine protease inhibitors on influenza virus infection of human airway epithelial cells, and on their production of inflammatory cytokines are unclear.
2.Inhibition of Protease-ENaC Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
Reihill JA1, Walker B2, Hamilton RA3, Ferguson TE4, Elborn JS5, Stutts MJ6, Harvey BJ7, Saint-Criq V8, Hendrick SM9, Martin SL10. Am J Respir Crit Care Med. 2016 Mar 25. [Epub ahead of print]
RATIONALE: In cystic fibrosis (CF) a reduction in airway surface liquid (ASL) height compromises mucociliary clearance, favoring mucus plugging and chronic bacterial infection. Inhibitors of ENaC have therapeutic potential in CF airways to reduce the hyper-stimulated sodium and fluid absorption to levels which can restore airways hydration.
3.Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.
Bardou O1,2, Menou A1,2, François C1,2, Duitman JW3, von der Thüsen JH4, Borie R2,5, Sales KU6,7, Mutze K8, Castier Y9, Sage E10, Liu L11, Bugge TH6, Fairlie DP11, Königshoff M8, Crestani B1,2,5, Borensztajn KS1,2. Am J Respir Crit Care Med. 2016 Apr 15;193(8):847-860.
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a devastating disease that remains refractory to current therapies.
4.Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
Narita Y1, Ueda M2, Uchimura K3, Kakizoe Y2, Miyasato Y2, Mizumoto T2, Morinaga J2, Hayata M2, Nakagawa T2, Adachi M2, Miyoshi T2, Sakai Y4, Kadowaki D1, Hirata S1, Mukoyama M2, Kitamura K5. J Pharmacol Sci. 2016 Feb;130(2):110-6. doi: 10.1016/j.jphs.2016.01.003. Epub 2016 Jan 20.
We previously reported that camostat mesilate (CM) had renoprotective and antihypertensive effects in rat CKD models. In this study, we examined if CM has a distinct renoprotective effect from telmisartan (TE), a renin-angiotensin-aldosterone system (RAS) inhibitor, on the progression of CKD. We evaluated the effect of CM (400 mg/kg/day) and/or TE (10 mg/kg/day) on renal function, oxidative stress, renal fibrosis, and RAS components in the adenine-induced rat CKD model following 5-weeks treatment period. The combination therapy with CM and TE significantly decreased the adenine-induced increase in serum creatinine levels compared with each monotherapy, although all treatment groups showed similar reduction in blood pressure. Similarly, adenine-induced elevation in oxidative stress markers and renal fibrosis markers were significantly reduced by the combination therapy relative to each monotherapy. Furthermore, the effect of the combination therapy on plasma renin activity (PRA) and plasma aldosterone concentration (PAC) was similar to that of TE monotherapy, and CM had no effect on both PRA and PAC, suggesting that CM has a distinct pharmacological property from RAS inhibition.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 72-69-5 nortriptyline

(CAS: 72-69-5)

Nortriptyline is a second-generation antidepressant originated by Lilly. It is a non-selective monoamine reuptake inhibitor. Nortriptyline can be used for the t...

CAS 140678-14-4 Mangafodipir Trisodium

Mangafodipir Trisodium
(CAS: 140678-14-4)

The trisodium salt form of Mangafodipir that has been found to be a contrast agent through intravenously Mangafodipir Trisodium is a contrast agent delivered in...

CAS 1982372-88-2 A 196

A 196
(CAS: 1982372-88-2)

A 196 is a potent and selective inhibitor of SUV420H1/H2 (IC50 = 25 and 144 nM, respectively) with 100-fold selectivity over other histone methyltransferases an...

(CAS: 171655-92-8)

NS-2214, an azabicyclo compound, has been found to be a dopamine uptake inhibitor that was once studied in the treatment of Parkinson's disease.

CAS 95737-68-1 Pyriproxyfen

(CAS: 95737-68-1)

Pyriproxyfen is a pyridine-based pesticide which is effective against a variety of arthropoda, in particular to protect cotton crops against whitefly. It is a j...

CAS 1083-57-4 Bucetin

(CAS: 1083-57-4)

Bucetin, a phenacetin analog, has antipyretic and analgesic effect. It has been discontinued for showing renal toxicity.

CAS 1627607-88-8 (S)-PFI 2 hydrochloride

(S)-PFI 2 hydrochloride
(CAS: 1627607-88-8)

(S)-PFI 2 hydrochloride, a negative control of (R)-PFI 2 hydrochloride which a potent, cell-permeable inhibitor of SET7/9 (IC50 = 2 nM), shows 500-fold lower ac...

CAS 36062-07-4 Octahydrocurcumin

(CAS: 36062-07-4)

OKT3-induced PBMC proliferation was inhibited by octahydrocurcumin with IC50 of 82 uM. The investigated substances with the strongest effect on radical scavengi...

CAS 106516-24-9 Sertindole

(CAS: 106516-24-9)

Sertindole, a neuroleptic, is one of the newer antipsychotic medications available.

CAS 68252-28-8 (R)-Oxiracetam

(CAS: 68252-28-8)

(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam, which is a nootropic drug of the racetam family and stimulant. It is safe even when high ...

CAS 102636-74-8 CINPA 1

(CAS: 102636-74-8)

CINPA 1 has been found to be a CAR antagonist and could exhibit activities in regulating the expression of genes involved in drug metabolism.

CAS 223580-51-6 Tiadinil

(CAS: 223580-51-6)

Tiadinil is a plant activator of systemic acquired resistance, boosts the production of herbivore-induced plant volatiles; insecticide agent.

CAS 719277-30-2 ProINDY

(CAS: 719277-30-2)

ProINDY, the prodrug form of INDY, is a cell permeable ATP-competitive DYRK1A/B inhibitor.

CAS 325746-94-9 BPIPP

(CAS: 325746-94-9)

BPIPP is a non-competitive guanylyl cyclase (GC) and adenylyl cyclase (AC) inhibitor. It downregulates cAMP and cGMP synthesis, suppresses cGMP accumulation in ...

CAS 52-21-1 Prednisolone Acetate

Prednisolone Acetate
(CAS: 52-21-1)

Prednisolone Acetate is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant agent.

CAS 131060-14-5 NB-598

(CAS: 131060-14-5)

SE inhibitor NB-598 significantly inhibited both basal and glucose-stimulated insulin secretion from mouse pancreatic islets. CaV channels were markedly inhibit...

CAS 16320-04-0 Gestrinone

(CAS: 16320-04-0)

Gestrinone, also called as R2323, is a synthetic steroid hormone occasionally used to treat endometriosis and it inhibits leiomyoma cells (IC50= 43.67 μM).

CAS 957230-65-8 Isofagomine D-Tartrate

Isofagomine D-Tartrate
(CAS: 957230-65-8)

The D-Tartrate salt form of Isofagomine, an imino pyranose compound, has been found to be a glucosylceramidase stimulant and could exhibit activity in Gaucher's...

CAS 80573-04-2 Balsalazide

(CAS: 80573-04-2)

Balsalazide is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease. It is a new 5-aminosalicylic acid (5-ASA) containing prodrug. It i...

CAS 1181081-71-9 CLP 257

CLP 257
(CAS: 1181081-71-9)

CLP 257 has been found to be a KCC2 K+-Cl- cotransporter activator and could alleviates hypersensitivity in rats with peripheral nerve injury.

Chemical Structure

CAS 59721-29-8 Camostat Mesilate

Quick Inquiry

Verification code

Featured Items